Massachusetts Financial Services Portfolio holdings
Massachusetts Financial Services (MFS), founded in 1924 and headquartered in Boston, Massachusetts, is a pioneering investment management firm credited with launching the first U.S. mutual fund, the Massachusetts Investors Trust. Managing hundreds of billions in assets, MFS offers a wide range of actively managed investment products, including equity, fixed-income, and balanced funds, serving institutional investors, financial advisors, and individuals globally. Known for its disciplined, research-driven approach, the firm emphasizes long-term value creation through fundamental analysis and a collaborative team structure, avoiding short-term market trends. With a legacy of innovation and a strong global presence, MFS remains a respected name in the asset management industry, balancing tradition with a focus on sustainable, client-centric investing.
Top Buys
| 1 |
Boston Scientific
BSX
|
+$527M |
| 2 |
Merck
MRK
|
+$516M |
| 3 |
ConocoPhillips
COP
|
+$462M |
| 4 |
Masco
MAS
|
+$397M |
| 5 |
NXP Semiconductors
NXPI
|
+$348M |
Top Sells
| 1 |
Wells Fargo
WFC
|
+$636M |
| 2 |
Bank of New York Mellon
BK
|
+$447M |
| 3 |
RTX Corp
RTX
|
+$428M |
| 4 |
Pfizer
PFE
|
+$412M |
| 5 |
3M
MMM
|
+$411M |
Sector Composition
| 1 | Technology | 19.84% |
| 2 | Financials | 18.12% |
| 3 | Healthcare | 16.64% |
| 4 | Industrials | 13.63% |
| 5 | Communication Services | 7.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
EVOP
601
DELISTED
EVO Payments, Inc. Class A Common Stock
EVOP
| $8.98M | ﹤0.01% |
586,757
+95,025
| +19% | +$1.45M |
|
602
Schrodinger
SDGR
$1.35B
| $8.69M | ﹤0.01% |
+201,607
| New | +$8.69M |
|
603
Marathon Petroleum
MPC
$55.1B
| $8.55M | ﹤0.01% |
362,026
-1,647,854
| -82% | -$38.9M |
|
604
CTS Corp
CTS
$1.22B
| $8.29M | ﹤0.01% |
333,081
-7,392
| -2% | -$184K |
|
605
Inspire Medical Systems
INSP
$2.33B
| $7.98M | ﹤0.01% |
132,306
-39,547
| -23% | -$2.38M |
|
606
Collegium Pharmaceutical
COLL
$1.18B
| $7.9M | ﹤0.01% |
483,566
-10,572
| -2% | -$173K |
|
607
Helmerich & Payne
HP
$2.08B
| $7.87M | ﹤0.01% |
503,080
+145,605
| +41% | +$2.28M |
|
|
TCDA
608
DELISTED
Tricida, Inc. Common Stock
TCDA
| $7.69M | ﹤0.01% |
349,327
+34,224
| +11% | +$753K |
|
609
10x Genomics
TXG
$1.62B
| $7.68M | ﹤0.01% |
123,301
-26,955
| -18% | -$1.68M |
|
610
Compañía de Cervecerías Unidas
CCU
$2.2B
| $7.55M | ﹤0.01% |
564,485
+28,948
| +5% | +$387K |
|
611
Tyson Foods
TSN
$19.7B
| $7.44M | ﹤0.01% |
128,509
-4,804
| -4% | -$278K |
|
|
PS
612
DELISTED
Pluralsight, Inc. Class A Common Stock
PS
| $7.14M | ﹤0.01% |
649,971
-1,757,572
| -73% | -$19.3M |
|
613
Amcor
AMCR
$18.9B
| $7.03M | ﹤0.01% |
865,435
-800,425
| -48% | -$6.5M |
|
614
Phreesia
PHR
$1.55B
| $7.02M | ﹤0.01% |
333,871
-81,710
| -20% | -$1.72M |
|
615
Ball Corp
BALL
$13.5B
| $7M | ﹤0.01% |
+108,174
| New | +$7M |
|
616
Magnolia Oil & Gas
MGY
$4.44B
| $6.94M | ﹤0.01% |
+1,735,864
| New | +$6.94M |
|
617
CSX Corp
CSX
$59.5B
| $6.91M | ﹤0.01% |
361,890
+353,481
| +4,204% | +$6.75M |
|
618
Coca-Cola
KO
$291B
| $6.85M | ﹤0.01% |
154,766
+1,969
| +1% | +$87.1K |
|
619
AT&T
T
$208B
| $6.8M | ﹤0.01% |
308,955
+111,490
| +56% | +$2.45M |
|
|
OPTN
620
DELISTED
OptiNose
OPTN
| $6.45M | ﹤0.01% |
95,814
+26,893
| +39% | +$1.81M |
|
621
Invesco Mortgage Capital
IVR
$515M
| $6.43M | ﹤0.01% |
188,570
+26,189
| +16% | +$893K |
|
622
Novo Nordisk
NVO
$241B
| $6.37M | ﹤0.01% |
211,770
+13,434
| +7% | +$404K |
|
|
IMMU
623
DELISTED
Immunomedics Inc
IMMU
| $6.21M | ﹤0.01% |
460,290
-10,659
| -2% | -$144K |
|
|
DEA
624
Easterly Government Properties
DEA
$1.04B
| $6.14M | ﹤0.01% |
99,736
+15,785
| +19% | +$972K |
|
625
BioXcel Therapeutics
BTAI
$54.3M
| $6.13M | ﹤0.01% |
+17,150
| New | +$6.13M |
|